[Federal Register Volume 60, Number 32 (Thursday, February 16, 1995)]
[Notices]
[Pages 9048-9049]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-3819]



=======================================================================
-----------------------------------------------------------------------

UNITED STATES INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-349]


Commission Decision To Extend by Ten Days the Deadline for 
Determining Whether To Review an Initial Determination

AGENCY: International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

    In the Matter of: Certain Diltiazem Hydrochloride and Diltiazem 
Preparations.

SUMMARY: Notice is hereby given that the Commission has extended by ten 
days, i.e., from March 20, 1995, to March 30, 1995, the deadline by 
which it must determine whether to review the presiding administrative 
law judge's final initial determination (ID) in the above-captioned 
investigation.

[[Page 9049]] FOR FURTHER INFORMATION CONTACT: Cynthia P. Johnson, 
Esq., Office of the General Counsel, U.S. International Trade 
Commission, 500 E Street, SW., Washington, DC 20436, telephone 202-205-
3098.

SUPPLEMENTARY INFORMATION: On February 2, 1994, the presiding 
administrative law judge (ALJ) issued his final ID in this 
investigation. The ALJ determined that no violation of section 337 of 
the Tariff Act of 1930, as amended, has occurred in the importation or 
sale of certain diltiazem hydrochloride and diltiazem preparations by 
reason of infringement of claim 1 of U.S. Letters Patent 4,438,035. 
Under Commission interim rule 210.53(h), the ID would have become the 
determination of the Commission on March 20, 1995, unless review was 
ordered or the review deadline extended.
    On February 6, 1995, complainants Tanabe Seiyaku Co., Ltd. and 
Marion Merrell Dow, Inc. filed a letter requesting a six-day extension 
of time--from February 15, 1995, until February 21, 1995--to file a 
petition for review of the ID. On February 7, respondents Mylan 
Pharmaceuticals, Inc., Mylan Laboratories, Inc., and Profarmaco Nobel 
LRL submitted a letter taking no position on complainants' request for 
an extension of time, but requesting, in the event the Commission 
grants complainants' request, a six-day extension of time--from 
February 28, 1995 to March 6, 1995--to file their response to 
complainants' petition for review. A similar request was made on 
February 8, 1995, by the Fermion respondents.
    This action is taken under the authority of section 337 of the 
Tariff Act of 1930 (19 U.S.C. 1337) and Commission interim rule 
210.53(h) (19 CFR 210.53(h)).
    Copies of the nonconfidential version of the ID and all other 
nonconfidential documents filed in connection with this investigation 
are or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone 202-205-2000. Hearing-impaired persons are advised that 
information on this matter can be obtained by contacting the 
Commission's TDD terminal on 202-205-1810.

    Issued: February 10, 1995.

    By order of the Commission.
Donna R. Koehnke,
Secretary.
[FR Doc. 95-3819 Filed 2-15-95; 8:45 am]
BILLING CODE 7020-02-P